CHINA BIOLOGIC PRODS HLDGS I - COM (CBPO)

Historical Institutional Holders from Q2 2017 to Q2 2021

All holders as of June 30, 2021
Q2 2021
Type / Class
Equity / COM
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2021 Q2 0 $0 -$1.74B 0
2021 Q1 14.7M $1.74B +$60.9M $118.41 87
2020 Q4 14.2M $1.68B +$25.8M $118.11 87
2020 Q3 14M $1.56B +$76.1M $111.14 86
2020 Q2 13.3M $1.36B +$171M $102.18 88
2020 Q1 12M $1.29B +$93.7M $107.93 84
2019 Q4 11.1M $1.29B -$522M $116.38 87
2019 Q3 15.6M $1.79B +$78.3M $114.47 89
2019 Q2 14.9M $1.42B +$61.5M $95.30 74
2019 Q1 14.3M $1.3B -$29.2M $91.25 69
2018 Q4 14.7M $1.11B -$435M $75.91 65
2018 Q3 17.4M $1.39B +$183M $80.00 81
2018 Q2 14.9M $1.48B -$316M $99.33 88
2018 Q1 18.2M $1.47B -$2.41M $81.00 82
2017 Q4 18.3M $1.44B +$75.3M $78.77 87
2017 Q3 17M $1.57B +$1.18B $92.27 84
2017 Q2 4.07M $461M +$461M $113.09 4